Systemic therapy with lenvatinib in advanced hepatocellular carcinoma: what to do in the case of a complete radiologic response?

Authors

  • Raffaele Emmanuele Maria Pirozzi Division of Obesity and Minimally Invasive Oncological General Surgery, A.O.U. Luigi Vanvitelli, Naples; Division of Hepatobiliary and Liver Transplantation Surgery, Department of Transplantation Surgery, A.O.R.N. Cardarelli, Napoli, Italy
  • Marcello Di Martino Division of Hepatobiliary and Liver Transplantation Surgery, Department of Transplantation Surgery, A.O.R.N. Cardarelli, Napoli, Italy
  • Daniele Ferraro Division of Hepatobiliary and Liver Transplantation Surgery, Department of Transplantation Surgery, A.O.R.N. Cardarelli, Napoli, Italy
  • Donatella Pisaniello Division of Hepatobiliary and Liver Transplantation Surgery, Department of Transplantation Surgery, A.O.R.N. Cardarelli, Napoli, Italy
  • Giovanni Vennarecci Division of Hepatobiliary and Liver Transplantation Surgery, Department of Transplantation Surgery, A.O.R.N. Cardarelli, Napoli, Italy

DOI:

https://doi.org/10.15403/jgld-4811

Keywords:

levantinib, hepatocellular carcinoma, HCC, complete radiologic response

Downloads

Published

2023-04-01

How to Cite

1.
Pirozzi REM, Di Martino M, Ferraro D, Pisaniello D, Vennarecci G. Systemic therapy with lenvatinib in advanced hepatocellular carcinoma: what to do in the case of a complete radiologic response?. JGLD [Internet]. 2023 Apr. 1 [cited 2025 Jul. 9];32(1):118-9. Available from: https://www.jgld.ro/jgld/index.php/jgld/article/view/4811

Issue

Vol. 32 No. 1: March 2023

Section

Letters